Synergistic targeting of cancer and associated angiogenesis using triple-targeted dual-drug silica nanoformulations for theragnostics. (Q39302009)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22865683%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

Synergistic targeting of cancer and associated angiogenesis using triple-targeted dual-drug silica nanoformulations for theragnostics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22865683%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22865683%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Srivani Veeranarayanan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22865683%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Aby Cheruvathoor Poulose

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22865683%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

M Sheikh Mohamed

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22865683%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Saino Hanna Varghese

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22865683%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Yutaka Nagaoka

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22865683%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Yasuhiko Yoshida

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22865683%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Toru Maekawa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22865683%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

3 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22865683%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22865683%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22865683%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22865683%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

3476-3489

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22865683%20AND%20SRC:MED&resulttype=core&format=json

Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics

10 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Targeted imaging and therapy of brain cancer using theranostic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Nanotechnology-mediated targeting of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Peptide-mediated cancer targeting of nanoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Rapid dissolution of ZnO nanocrystals in acidic cancer microenvironment leading to preferential apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Quantifying the cellular uptake of antibody-conjugated Au nanocages by two-photon microscopy and inductively coupled plasma mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Cancer nanotechnology: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Reshaping the future of nanopharmaceuticals: ad iudicium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Targeting the DNA damage response in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Targeting of porous hybrid silica nanoparticles to cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

PEG coated biocompatible cadmium chalcogenide quantum dots for targeted imaging of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery: improved water suspensibility and decreased nonspecific protein binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

FITC labeled silica nanoparticles as efficient cell tags: uptake and photostability study in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Understanding microtubule dynamics for improved cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Promotion of microtubule assembly in vitro by taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Suramin suppresses growth, alkaline-phosphatase and telomerase activity of human osteosarcoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874

Synergistic targeting of alphavbeta3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200874